These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 37330973
1. Catalogues of EQ-5D-3L Health-Related Quality of Life Scores for 199 Chronic Conditions and Health Risks for Use in the UK and the USA. Falk Hvidberg M, Hernández Alava M. Pharmacoeconomics; 2023 Oct; 41(10):1287-1388. PubMed ID: 37330973 [Abstract] [Full Text] [Related]
3. An evaluation of EQ-5D-3L health utility scores using five country-specific tariffs in a rural population aged 45-69 years in Hua county, Henan province, China. Wang H, Cao C, Guo C, He Y, Li F, Xu R, Liu M, Liu Z, Pan Y, Liu F, Liu Y, Li J, Cai H, He Z, Ke Y. Health Qual Life Outcomes; 2020 Jul 13; 18(1):228. PubMed ID: 32660494 [Abstract] [Full Text] [Related]
5. Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping. Gray LA, Wailoo AJ, Hernandez Alava M. Value Health; 2018 Dec 13; 21(12):1399-1405. PubMed ID: 30502783 [Abstract] [Full Text] [Related]
6. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery. Gandhi M, Ang M, Teo K, Wong CW, Wei YC, Tan RL, Janssen MF, Luo N. Patient; 2019 Aug 13; 12(4):383-392. PubMed ID: 30607809 [Abstract] [Full Text] [Related]
8. Health-related quality of life in residents aged 18 years and older with and without disease: findings from the First Provincial Health Services Survey of Hunan, China. Deng X, Dong P, Zhang L, Tian D, Zhang L, Zhang W, Li L, Deng J, Ning P, Hu G. BMJ Open; 2017 Sep 03; 7(9):e015880. PubMed ID: 28871016 [Abstract] [Full Text] [Related]
10. Comparing and transforming PROMIS utility values to the EQ-5D. Hartman JD, Craig BM. Qual Life Res; 2018 Mar 03; 27(3):725-733. PubMed ID: 29264776 [Abstract] [Full Text] [Related]
14. A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions. Shaw JW, Bennett B, Trigg A, DeRosa M, Taylor F, Kiff C, Ntais D, Noon K, King MT, Cocks K. Value Health; 2021 Nov 03; 24(11):1651-1659. PubMed ID: 34711366 [Abstract] [Full Text] [Related]
16. Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility: A Bayesian Approach. Pullenayegum EM, Chan KK, Xie F. Med Decis Making; 2016 Feb 03; 36(2):223-33. PubMed ID: 26139449 [Abstract] [Full Text] [Related]
17. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter? Yang F, Devlin N, Luo N. Value Health; 2019 Jan 03; 22(1):45-49. PubMed ID: 30661633 [Abstract] [Full Text] [Related]
18. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis. Pickard AS, Gooderham M, Hartz S, Nicolay C. J Med Econ; 2017 Jan 03; 20(1):19-27. PubMed ID: 27471948 [Abstract] [Full Text] [Related]
19. Mapping the COPD Assessment Test onto EQ-5D. Hoyle CK, Tabberer M, Brooks J. Value Health; 2016 Jun 03; 19(4):469-77. PubMed ID: 27325339 [Abstract] [Full Text] [Related]